Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S van der Flier

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of the National Cancer Institute|January 20, 2000
Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatmentS van der Flier, A Brinkman, M P Look, et al.
Drugs|November 6, 2001
Tamoxifen resistance in breast cancer: elucidating mechanismsL C Dorssers, S Van der Flier, A Brinkman, et al.
The International Journal of Biological Markers|October 19, 2001
Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissueS van der Flier, T H van der Kwast, C J Claassen, et al.
Breast (Edinburgh, Scotland)|November 22, 2021
Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancerR K Ismail, J van Breeschoten, M W J M Wouters, et al.
Breast (Edinburgh, Scotland)|February 22, 2022
Response to: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?R K Ismail, J van Breeschoten, M W J M Wouters, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of the National Cancer Institute|January 20, 2000
Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatmentS van der Flier, A Brinkman, M P Look, et al.
Drugs|November 6, 2001
Tamoxifen resistance in breast cancer: elucidating mechanismsL C Dorssers, S Van der Flier, A Brinkman, et al.
The International Journal of Biological Markers|October 19, 2001
Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissueS van der Flier, T H van der Kwast, C J Claassen, et al.
Breast (Edinburgh, Scotland)|November 22, 2021
Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancerR K Ismail, J van Breeschoten, M W J M Wouters, et al.
Breast (Edinburgh, Scotland)|February 22, 2022
Response to: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?R K Ismail, J van Breeschoten, M W J M Wouters, et al.
Pageof 2